ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,277.51
0.80%
Dow Jones
38,686.32
1.51%
US Dollar vs MXN
16.99024
-0.30%
Brent Oil
81.295
0.00%
Bitcoin
67,699.24
0.32%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NYSE
  6. Danaher Corporation (DHR)

  7. Danaher Corporation (DHR) Noticias

DHR

Danaher (DHR)

Danaher Corporation
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NYSE:DHR
FechaHoraFuenteTítuloSímboloCompañía
09/05/202406:00PR Newswire (US)Danaher Launches Collaboration with Johns Hopkins University Aiming to Improve Neurological DiagnosisNYSE:DHRDanaher Corporation
07/05/202415:45PR Newswire (US)Danaher to Present at Bank of America Securities Healthcare ConferenceNYSE:DHRDanaher Corporation
07/05/202415:15PR Newswire (US)Danaher Announces Quarterly DividendNYSE:DHRDanaher Corporation
03/05/202408:06PR Newswire (US)Curiox Biosystems and Beckman Coulter Life Sciences Announce a Partnership Combining C-FREE™ Technology with DURA Innovations for Hands-Free Washed Sample Preparation for Flow CytometryNYSE:DHRDanaher Corporation
23/04/202405:00PR Newswire (US)Danaher Reports First Quarter 2024 ResultsNYSE:DHRDanaher Corporation
21/03/202415:15PR Newswire (US)Danaher Schedules First Quarter 2024 Earnings Conference CallNYSE:DHRDanaher Corporation
27/02/202415:15PR Newswire (US)Danaher to Present at TD Cowen Health Care ConferenceNYSE:DHRDanaher Corporation
22/02/202415:15PR Newswire (US)Danaher Commits to Set Science-Based, Net-Zero Greenhouse Gas Emission Reduction TargetsNYSE:DHRDanaher Corporation
05/02/202406:30PR Newswire (US)Danaher Launches Collaboration with Cincinnati Children's Hospital Medical Center Aiming to Improve Patient Safety in Early Drug DevelopmentNYSE:DHRDanaher Corporation
30/01/202405:00PR Newswire (US)Danaher Reports Fourth Quarter and Full Year 2023 ResultsNYSE:DHRDanaher Corporation
09/01/202406:30PR Newswire (US)Danaher, Jennifer Doudna, and Innovative Genomics Institute Launch Danaher-IGI Beacon for CRISPR Cures with Aim to Address Hundreds of Diseases Using Gene-editing Platform SolutionNYSE:DHRDanaher Corporation
08/01/202415:57Dow Jones NewsDanaher Says 4Q Adjusted. Revenue to Fall by Less Than ForecastNYSE:DHRDanaher Corporation
08/01/202415:15PR Newswire (US)Danaher CEO to Comment on Financial PerformanceNYSE:DHRDanaher Corporation
02/01/202416:00PR Newswire (US)Danaher to Present at J.P. Morgan Healthcare ConferenceNYSE:DHRDanaher Corporation
21/12/202315:30PR Newswire (US)Danaher Schedules Fourth Quarter 2023 Earnings Conference CallNYSE:DHRDanaher Corporation
13/12/202315:06GlobeNewswire Inc.Codexis and Aldevron Enter Exclusive Licensing Agreement for Codex® HiCap RNA PolymeraseNYSE:DHRDanaher Corporation
06/12/202306:30PR Newswire (US)Danaher Completes Acquisition of AbcamNYSE:DHRDanaher Corporation
05/12/202316:14Dow Jones NewsDanaher Cuts Quarterly Dividend to 24 CentsNYSE:DHRDanaher Corporation
21/11/202315:15PR Newswire (US)Danaher to Present at Evercore ISI HealthCONx ConferenceNYSE:DHRDanaher Corporation
21/11/202313:22Dow Jones NewsDanaher on Track for Largest Percent Increase in Almost a Year -- Data TalkNYSE:DHRDanaher Corporation
31/10/202306:30PR Newswire (US)Danaher appoints Christopher Riley to Executive Vice President for BiotechnologyNYSE:DHRDanaher Corporation
24/10/202305:41Dow Jones NewsDanaher 3Q Earnings, Sales Decline but Beat EstimatesNYSE:DHRDanaher Corporation
24/10/202305:00PR Newswire (US)Danaher Reports Third Quarter 2023 ResultsNYSE:DHRDanaher Corporation
17/10/202305:34IH Market NewsKeep An Eye Out: Pre-Market Movers And Analyst RecommendationsNYSE:DHRDanaher Corporation
30/09/202307:00PR Newswire (US)Danaher Corporation Completes Separation of Veralto CorporationNYSE:DHRDanaher Corporation
28/09/202317:17PR Newswire (US)Veralto Set to Join S&P 500; Vestis to Join S&P MidCap 400; Others to Join S&P SmallCap 600NYSE:DHRDanaher Corporation
26/09/202315:15PR Newswire (US)Danaher Schedules Third Quarter 2023 Earnings Conference CallNYSE:DHRDanaher Corporation
19/09/202306:43PR Newswire (US)Danaher to Provide Cepheid's Tuberculosis Test to the Global Fund at CostNYSE:DHRDanaher Corporation
12/09/202308:23IH Market NewsKeep An Eye Out: Pre-Market Movers And RecommendationsNYSE:DHRDanaher Corporation
12/09/202304:45PR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Danaher Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 15, 2023 - (NYSE: DHR)NYSE:DHRDanaher Corporation
 Showing the most relevant articles for your search:NYSE:DHR

Su Consulta Reciente

FX
EURMXN
Euro vs MXN
NASDAQ
GOOGL
Alphabet
NASDAQ
TSLA
Tesla
NASDAQ
NVDA
NVIDIA
NASDAQ
AMZN
Amazon.com
COIN
ETHUSD
Ethereum
CCOM
OILBRENT
Brent Oil
AMEX
SPY
SPDR S&P 500
NASDAQ
QQQ
Invesco QQQ Trust Series 1
COIN
BTCUSD
Bitcoin
NYSE
VZ
Verizon Communications
COIN
SOLUSD
Solana
NYSE
BAC
Bank of America
CCOM
US500
US 500
NYSE
MCD
McDonalds
NYSE
MRK
Merck
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados